VPS70 Antibody

Shipped with Ice Packs
In Stock

Description

Biological Context of VPS70

VPS70 is referenced in yeast (Saccharomyces cerevisiae) studies as a potential protease involved in vacuolar protein sorting and secretory pathway regulation. Key findings include:

  • Role in Secretion Enhancement: Disruption of VPS70 in ∆ypt7 and ∆vam6 yeast strains (defective in HOPS complex subunits) further improved secretion efficiency of recombinant proteins like carboxylesterase (CES) and HyHEL-Fab .

  • Protease Activity: VPS70 is hypothesized to contribute to vacuolar proteolysis, as its deletion reduced degradation of secreted proteins when combined with vacuolar protease Pep4 .

Functional Characterization of VPS70

The table below summarizes experimental observations from yeast studies involving VPS70 disruption:

ParameterObservation in ΔVPS70 StrainsCitation
Protein SecretionEnhanced secretion in ∆ypt7 and ∆vam6 backgrounds
Protease ActivityReduced degradation of secreted proteins with Pep4 co-deletion
Synergy with HOPS MutantsImproved yields of HyHEL-Fab (46–73% over controls)

Antibody-Specific Insights

  • Validation Protocols: Standardized assays for Western blot (WB), immunoprecipitation (IP), and immunofluorescence (IF) using knockout cell lines, as demonstrated for hVPS35 antibodies .

  • Commercial Antibody Gaps: While multiple antibodies for retromer complex proteins (e.g., VPS35) are commercially available and validated , no equivalent resources were identified for VPS70 in the reviewed literature.

Research Implications

The absence of VPS70 antibody data highlights a gap in current proteomic tools. Future studies could adopt the following framework:

  1. Antibody Generation: Develop monoclonal or polyclonal antibodies using recombinant VPS70 protein.

  2. Validation Pipeline:

    • WB: Compare signals in wild-type vs. VPS70 knockout yeast or mammalian cell lines.

    • IP: Assess ability to immunoprecipitate VPS70 from cell lysates.

    • Localization: Use immunofluorescence to confirm subcellular distribution (e.g., vacuolar/endosomal compartments).

Limitations and Future Directions

  • Evolutionary Conservation: VPS70’s role in higher eukaryotes remains uncharacterized, limiting extrapolation to human systems.

  • Technical Challenges: Antibody cross-reactivity risks due to homology with other vacuolar proteases (e.g., Pep4, Prb1) necessitate rigorous specificity testing .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
VPS70 antibody; YJR126C antibody; J2050Vacuolar protein sorting-associated protein 70 antibody; EC 3.4.-.- antibody
Target Names
VPS70
Uniprot No.

Target Background

Function
VPS70 Antibody plays a role in vacuolar protein sorting.
Database Links

KEGG: sce:YJR126C

STRING: 4932.YJR126C

Protein Families
Peptidase M28 family, M28B subfamily
Subcellular Location
Membrane; Single-pass membrane protein.

Q&A

What is VPS70 and what cellular functions does it perform?

VPS70 (Vacuolar Protein Sorting 70) is a potential protease involved in the vacuolar protein sorting pathway in yeast. It plays a significant role in protein trafficking and secretion mechanisms. Studies have shown that disruption of VPS70 in certain yeast strains (particularly Δypt7 and Δvam6) leads to enhanced secretion of recombinant proteins, suggesting its involvement in protein retention mechanisms . The protein is part of the complex cellular machinery that regulates protein movement between organelles, particularly affecting the trafficking between Golgi and vacuolar compartments.

What are the recommended applications for VPS70 antibodies in research?

VPS70 antibodies can be utilized in several research applications including:

  • Western blotting for detection and quantification of VPS70 protein levels

  • Immunoprecipitation to study protein-protein interactions

  • Immunofluorescence microscopy to visualize subcellular localization

  • Flow cytometry for detecting VPS70 in cell populations

For optimal results in these applications, researchers should validate antibody specificity using knockout controls and titrate the antibody concentration specific to their experimental system, similar to protocols established for other vacuolar protein antibodies .

How can researchers validate VPS70 antibody specificity?

Validating VPS70 antibody specificity involves:

Validation MethodImplementationExpected Outcome
Knockout/KnockdownUsing VPS70-null strains or gene silencingAbsence of signal in Western blot/immunostaining
OverexpressionComparing wild-type to VPS70-overexpressing cellsIncreased signal intensity proportional to expression
Peptide competitionPre-incubating antibody with purified VPS70 peptideDiminished or eliminated signal
Cross-reactivity testingTesting against related VPS family proteinsSignal specific only to VPS70

Additionally, comparing results using multiple antibodies targeting different epitopes of VPS70 can provide further validation of specificity .

How do VPS70 antibodies facilitate investigation of vacuolar protein sorting mechanisms?

VPS70 antibodies enable detailed investigation of vacuolar protein sorting by:

  • Allowing visualization of VPS70 relocalization during vacuolar morphogenesis

  • Enabling quantitative assessment of VPS70 expression levels in different genetic backgrounds

  • Facilitating identification of novel VPS70 interaction partners through co-immunoprecipitation

  • Permitting real-time tracking of VPS70 dynamics during cellular responses to stress

These capabilities are particularly valuable when studying how disruption of HOPS complex components (like Ypt7 and Vam6) affects VPS70 localization and function in protein secretion pathways .

What is the relationship between VPS70 expression and recombinant protein secretion?

Research has established a significant inverse correlation between VPS70 expression and recombinant protein secretion. When VPS70 is disrupted in conjunction with HOPS complex components:

Strain ConfigurationHyHEL-Fab Secretion IncreaseCES Secretion Increase
Δypt746%40%
Δvam641%73%
Δypt7Δvps7062%Not reported
Δvam6Δvps7068%Not reported

These data demonstrate that VPS70 disruption significantly enhances recombinant protein secretion, particularly when combined with mutations in HOPS complex components, suggesting VPS70 plays a role in protein retention within the cell .

How can researchers use VPS70 antibodies to study its protease activity?

To investigate VPS70's putative protease activity, researchers can:

  • Perform in vitro protease assays with immunoprecipitated VPS70

  • Use VPS70 antibodies to track protease activity in subcellular fractions

  • Conduct pulse-chase experiments with VPS70 antibodies to monitor substrate degradation

  • Employ proximity labeling techniques with VPS70 antibodies to identify potential substrates

Designing experiments that compare wild-type VPS70 to mutant versions with altered catalytic sites can further elucidate its protease mechanisms and substrate specificity .

What are optimal protocols for Western blotting with VPS70 antibodies?

For effective Western blotting with VPS70 antibodies:

  • Sample preparation:

    • Lyse cells in buffer containing protease inhibitors to prevent degradation

    • Perform subcellular fractionation if studying VPS70 in specific compartments

  • Electrophoresis and transfer:

    • Use 10-12% SDS-PAGE gels for optimal separation

    • Transfer proteins to PVDF membranes at 100V for 1 hour in cold conditions

  • Antibody incubation:

    • Block membranes with 5% non-fat milk or BSA for 1 hour

    • Incubate with primary VPS70 antibody (1:500-1:2000 dilution) overnight at 4°C

    • Wash thoroughly and incubate with appropriate secondary antibody

  • Detection:

    • Use enhanced chemiluminescence for sensitive detection

    • Expected molecular weight for VPS70 should be confirmed based on species-specific data

How should immunofluorescence experiments with VPS70 antibodies be optimized?

For optimal immunofluorescence results:

ParameterRecommendationRationale
Fixation4% paraformaldehyde (10 minutes)Preserves protein structure while maintaining antigenicity
Permeabilization0.1% Triton X-100 (5 minutes)Allows antibody access while preserving vacuolar structures
Blocking3% BSA in PBS (30 minutes)Reduces non-specific binding
Primary antibody1:100-1:500 dilution (overnight, 4°C)Balances signal strength with specificity
Secondary antibodySpecies-appropriate fluorophore-conjugated (1:500, 1 hour, RT)Enables visualization while minimizing background
CounterstainingDAPI for nuclei; FM4-64 for vacuolar membranesProvides context for VPS70 localization

These parameters should be optimized for specific experimental conditions and cell types .

How can researchers troubleshoot non-specific binding of VPS70 antibodies?

When encountering non-specific binding:

  • Increase blocking duration and concentration (try 5% BSA or 10% normal serum)

  • Perform more stringent washing (add 0.1% Tween-20 to wash buffers)

  • Titrate antibody concentration to determine optimal signal-to-noise ratio

  • Pre-absorb antibody with cell lysate from VPS70-null cells

  • Ensure appropriate negative controls are included in each experiment

  • Consider using monoclonal antibodies if polyclonal antibodies show excessive cross-reactivity

Careful validation using knockout controls remains the gold standard for confirming binding specificity .

How should researchers interpret VPS70 antibody data in relation to genetic disruption studies?

When comparing antibody-based studies with genetic disruption experiments:

  • Antibody detection reveals protein presence but not necessarily activity

  • Genetic disruption studies show functional consequences but may trigger compensatory mechanisms

  • Discrepancies between protein detection and genetic phenotypes may indicate:

    • Post-translational regulation

    • Functional redundancy

    • Context-dependent activity

    • Technical limitations in antibody sensitivity

Researchers should integrate data from multiple approaches, including genomic, proteomic, and functional studies. For example, the enhanced secretion phenotype in Δvps70 mutants provides functional evidence that should be correlated with protein expression patterns detected by antibodies .

How can VPS70 antibodies be used in combination with other HOPS complex component antibodies?

Combining VPS70 antibodies with antibodies against other HOPS components enables:

  • Multiplexed detection of protein complexes via co-immunoprecipitation

  • Visualization of co-localization patterns through multi-color immunofluorescence

  • Sequential immunoprecipitation to isolate specific subcomplexes

  • Analysis of stoichiometric relationships within protein assemblies

This approach is particularly valuable when studying how disruption of one HOPS component (e.g., Ypt7 or Vam6) affects the localization and function of VPS70 and other interacting proteins .

What novel approaches are emerging for studying VPS70 using antibody-based technologies?

Emerging technologies for VPS70 research include:

  • Proximity labeling techniques (BioID, APEX) using VPS70 antibodies to map protein interaction networks

  • Single-molecule tracking with fluorescently-labeled antibody fragments to study VPS70 dynamics

  • Super-resolution microscopy combined with VPS70 immunolabeling to visualize nanoscale localization

  • Antibody-based proteomics to identify post-translational modifications of VPS70

  • De novo designed antibodies using computational approaches like those described for other challenging targets

These approaches are expanding our ability to study VPS70's role in vacuolar protein sorting with unprecedented precision and detail.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.